Treatment of solid organ transplant patients with invasive fungal infections: should a combination of antifungal drugs be used?

@article{Muoz2006TreatmentOS,
  title={Treatment of solid organ transplant patients with invasive fungal infections: should a combination of antifungal drugs be used?},
  author={Patricia Mu{\~n}oz and Niveet Singh and E. Fern{\'a}ndez Bouza},
  journal={Current opinion in infectious diseases},
  year={2006},
  volume={19 4},
  pages={
          365-70
        }
}
PURPOSE OF REVIEW Combined antifungal drug therapy is widely used in severe invasive mycoses in solid organ transplant (SOT) recipients. We have reviewed the available data in the literature. RECENT FINDINGS No single randomized study on antifungal combination therapy in SOT patients has been performed. Existing information does not support the use of combination therapy in invasive candidiasis in SOT patients. Indeed, initial combination therapy with amphotericin B and 5-flucytosine is… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 25 CITATIONS

Phaeohyphomycosis in Transplant Patients

  • Journal of fungi
  • 2015
VIEW 1 EXCERPT
CITES BACKGROUND

ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others.

  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2014

Similar Papers